RedHill Biopharma Ltd.: RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia for the United Arab Emirates

Gaelan Medical to pay RedHill $2 million upfront plus potential regulatory and sales milestones and tiered royalties on net sales, for the exclusive rights in the United Arab Emirates

Related Keywords

United States ,Taipei ,T Ai Pei ,Taiwan ,United Arab Emirates ,Qatar ,Australia ,United Kingdom ,Israel ,Kuwait ,Belgium ,Saudi Arabia ,Jordan ,Turkey ,Bahrain ,Woman ,Americans ,Amber Fennell ,Dror Ben Asher ,Bryan Gibbs ,Redhill Biopharma ,Ghassan Aboud ,Adi Frish ,National Cancer Institute ,World Health Organization ,Ghassan Aboud Group ,Leey Asian Pacific Alliance On Helicobacter ,Redhill Biopharma Ltd ,Nasdaq ,Company Annual Report On Form ,Exchange Commission ,End Results Program ,Company Expanded Access Program ,Gaelan Medical Trade ,Corporate Business Development ,Gulf Cooperation Council Region Saudi Arabia ,Prnewswire Redhill Biopharma Ltd ,Gaelan Medical ,Hill Biopharma ,Gulf Cooperation Council ,Gaelen Medical ,Aboud Group ,Tubulointerstitial Nephritis ,Private Securities Litigation Reform Act ,Expanded Access Program ,Annual Report ,Finn Partners ,Middle East ,Leey Asian Pacific Alliance ,Its Associated Factors ,Healthy Asymptomatic Residents ,United Arab ,Systematic Review ,Cell Biochem ,Cancer Institute ,Florence Consensus Report ,Redhill ,Iopharma ,Maelan ,Medical ,Winter ,Into ,License ,Agreement ,Galicia ,United ,Rab ,Emirates ,